You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (13)

Journals (0)

1-10 of 13 results for RED MARROW DOSIMETRY

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Correlation of Red Marrow Radiation Dosimetry with Myelotoxicity: Empirical Factors Influencing the Radiation-Induced Myelotoxicity of Radiolabeled Antibodies,Fragments and Peptides in Pre-Clinical and Clinical Settings

Retricted access

Research article

First published 2002-08

Correlation of Red Marrow Radiation Dosimetry with Myelotoxicity: Empirical Factors Influencing the Radiation-Induced Myelotoxicity of Radiolabeled Antibodies,Fragments and Peptides in Pre-Clinical and Clinical Settings

Thomas M. Behr, Martin Béhé, George Sgouros

Cancer Biotherapy and Radiopharmaceuticals

Select article: Update: Establishing a Clinically Meaningful Predictive Model of Hematologic Toxicity in Nonmyeloablative Targeted Radiotherapy: Practical Aspects and Limitations of Red Marrow Dosimetry

Retricted access

Research article

First published 2005-04

Update: Establishing a Clinically Meaningful Predictive Model of Hematologic Toxicity in Nonmyeloablative Targeted Radiotherapy: Practical Aspects and Limitations of Red Marrow Dosimetry

Jeffry A. Siegel

Cancer Biotherapy and Radiopharmaceuticals

Select article: Sensitivity of Model-Based Calculations of Red Marrow Dosimetry to Changes in Patient-Specific Parameters

Retricted access

Research article

First published 2002-10

Sensitivity of Model-Based Calculations of Red Marrow Dosimetry to Changes in Patient-Specific Parameters

Michael G. Stabin, Jeffry A. Siegel, Richard B. Sparks

Cancer Biotherapy and Radiopharmaceuticals

Select article: Personalized Dosimetry of 131 I-Rituximab Radioimmunotherapy of Non-Hodgkin Lymphoma Defined by Pharmacokinetics in Bone Marrow and Blood

Retricted access

Research article

First published 2014-02

Personalized Dosimetry of 131 I-Rituximab Radioimmunotherapy of Non-Hodgkin Lymphoma Defined by Pharmacokinetics in Bone Marrow and Blood

Jan A. Boucek, J. Harvey Turner

Cancer Biotherapy and Radiopharmaceuticals

Select article: Pharmacokinetics and Dosimetry of 111 In/ 188 Re-Labeled PEGylated Liposomal Drugs in Two Colon Carcinoma-Bearing Mouse Models

Retricted access

Research article

First published 2011-06

Pharmacokinetics and Dosimetry of 111 In/ 188 Re-Labeled PEGylated Liposomal Drugs in Two Colon Carcinoma-Bearing Mouse Models

Yi-Yu Lin, Chih-Hsien Chang, Jia-Je Li [...]

Cancer Biotherapy and Radiopharmaceuticals

Select article: Additional Radiation Absorbed Dose Estimates for Zevalin™ Radioimmunotherapy

Retricted access

Research article

First published 2003-04

Additional Radiation Absorbed Dose Estimates for Zevalin™ Radioimmunotherapy

Gregory A. Wiseman, Bryan R. Leigh, William L. Dunn [...]

Cancer Biotherapy and Radiopharmaceuticals

Select article: Targeted alpha-particle therapy: imaging,dosimetry,and radiation protection

Free access

Research article

First published 2018-10

Targeted alpha-particle therapy: imaging,dosimetry,and radiation protection

M. Lassmann, U. Eberlein

Annals of the ICRP

Select article: Radiation Dosimetry Results From a Phase II Trial of Ibritumomab Tiuxetan (Zevalin™) Radioimmunotherapy for Patients With Non-Hodgkin's Lymphoma and Mild Thrombocytopenia

Retricted access

Research article

First published 2003-04

Radiation Dosimetry Results From a Phase II Trial of Ibritumomab Tiuxetan (Zevalin™) Radioimmunotherapy for Patients With Non-Hodgkin's Lymphoma and Mild Thrombocytopenia

Gregory A. Wiseman, Bryan R. Leigh, William D. Erwin [...]

Cancer Biotherapy and Radiopharmaceuticals

Select article: The Role of Dosimetry in the High Activity 90 Y-Ibritumomab Tiuxetan Regimens: Two Cases of Abnormal Biodistribution

Retricted access

Case report

First published 2009-04

The Role of Dosimetry in the High Activity 90 Y-Ibritumomab Tiuxetan Regimens: Two Cases of Abnormal Biodistribution

Demetrio Aricò, Chiara Maria Grana, Anna Vanazzi [...]

Cancer Biotherapy and Radiopharmaceuticals

Select article: Human Biodistribution and Radiation Dosimetry of the Targeting Fibroblast Growth Factor Receptor 1-Positive Tumors Tracer [ 68 Ga]Ga-DOTA-FGFR1-Peptide

Retricted access

Research article

First published 2024-12

Human Biodistribution and Radiation Dosimetry of the Targeting Fibroblast Growth Factor Receptor 1-Positive Tumors Tracer [ 68 Ga]Ga-DOTA-FGFR1-Peptide

Huiqing Yuan, Xiaoshan Chen, Mengmeng Zhao [...]

Cancer Biotherapy and Radiopharmaceuticals

1
2
10 / page

Article type

Publication date

Subjects

Access